DV, L., TS, T., TM, N., CN, W., DA, W., & GH, N. (2026). Vaccine-associated nonscarring immune-mediated alopecia: Insights from a pharmacovigilance analysis of the Vaccine Adverse Event Reporting System. Journal of the American Academy of Dermatology, 94(4), 1263. https://doi.org/10.1016/j.jaad.2025.12.021
Chicago Style (17th ed.) CitationDV, Le, Tran TS, Nguyen TM, Wieland CN, Wetter DA, and Nguyen GH. "Vaccine-associated Nonscarring Immune-mediated Alopecia: Insights from a Pharmacovigilance Analysis of the Vaccine Adverse Event Reporting System." Journal of the American Academy of Dermatology 94, no. 4 (2026): 1263. https://doi.org/10.1016/j.jaad.2025.12.021.
MLA (9th ed.) CitationDV, Le, et al. "Vaccine-associated Nonscarring Immune-mediated Alopecia: Insights from a Pharmacovigilance Analysis of the Vaccine Adverse Event Reporting System." Journal of the American Academy of Dermatology, vol. 94, no. 4, 2026, p. 1263, https://doi.org/10.1016/j.jaad.2025.12.021.